Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Clasificación en acciones #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Precio por acción
$154.51
Capitalización bursátil
$55.98B
Cambio (1 día)
-1.82%
Cambio (1 año)
-32.08%
País
US
Comercio Becton, Dickinson and Company (BDX)

Categoría

Ingresos de Becton, Dickinson and Company (BDX)
Ingresos en Dec 2025 TTM: $21.92B
Según los últimos informes financieros de Becton, Dickinson and Company, los ingresos actuales de la empresa (TTM) son $21.92B. En 2024, la empresa obtuvo unos ingresos de $20.18B un aumento con respecto a los ingresos del año 2023, que fueron de $19.37B. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Becton, Dickinson and Company desde 2000 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
2026 (TTM) $21.92B 0.38%
2025 $21.84B 8.23%
2024 $20.18B 4.16%
2023 $19.37B 2.66%
2022 $18.87B -1.36%
2021 $19.13B 19.02%
2020 $16.07B -7.03%
2019 $17.29B 8.18%
2018 $15.98B 32.17%
2017 $12.09B -3.12%
2016 $12.48B 21.41%
2015 $10.28B 21.74%
2014 $8.45B 4.87%
2013 $8.05B 4.49%
2012 $7.71B 1.64%
2011 $7.58B 6.45%
2010 $7.12B 1.97%
2009 $6.99B -1.25%
2008 $7.07B 11.25%
2007 $6.36B 10.83%
2006 $5.74B 5.97%
2005 $5.41B 9.73%
2004 $4.93B 10.56%
2003 $4.46B 12.70%
2002 $3.96B 5.49%
2001 $3.75B 3.76%
2000 $3.62B 0.00%
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
$10.06B -54.09%
US
$4.14B -81.12%
DE
$5.91B -73.04%
JP
$10.40B -52.56%
CH
$5.40B -75.38%
US